Aurora Cannabis Launches $100 Million At-The-Market Offering Program for Growth and Expansion

Aurora Cannabis Announces New Offering Program

Aurora Cannabis Inc., a prominent player in the global medical cannabis sector, has recently revealed its plan to launch an at-the-market offering program. Through this initiative, the company aims to raise up to $100 million by issuing common shares from its treasury to the public. This move is strategically designed to bolster its financial position and support ongoing growth initiatives.

With this ATM program, Aurora intends to make the most of its operational flexibility by distributing shares directly in the market at prevailing prices. Such an approach, which involves a range of distribution avenues including transactions in the U.S. marketplace, allows the company access to the capital needed to execute strategic investments. The proceeds from this offering will be exclusively allocated for capacity enhancement and furthering M&A activities, thereby reinforcing Aurora’s commitment to adapting and scaling within the competitive cannabis landscape.

The ATM program will function under a sales agreement established on February 4, 2026, with TD Securities (USA) LLC, solidifying a partnership that aims to optimize Aurora’s market presence while also ensuring compliance with regulatory frameworks. The company has formally filed the necessary prospectus supplement to align this offering with requirements set forth by securities commissions across various Canadian provinces, alongside the U.S. Securities and Exchange Commission (SEC).

Aurora Cannabis has carved out a significant niche within the medical cannabis industry, driven by its commitment to quality and patient care. The company’s innovative strategies have positioned it as a leader in both the medical and consumer cannabis markets, serving regions across Canada, Europe, Australia, and New Zealand. Its suite of trusted brands, including MedReleaf, Pedanios, and Whistler Cannabis Co., underscores its reputation for delivering high-quality products.

Furthermore, Aurora holds significant production capabilities through its GMP-certified facilities in Canada and Germany, enabling it to meet high standards of safety and efficacy. By introducing an ATM program, the company is not just looking at immediate financial gains, but is strategically positioning itself for long-term sustainability and growth.

The decision to pursue this funding method presents a calculated risk amid evolving market dynamics, including fluctuating demand and competition. Aurora's management believes that the reliable inflow of funds will facilitate its ongoing investment in infrastructure, expansion, and cultivation capacity, necessary for maintaining its edge in the competitive cannabis landscape.

Despite the positive outlook, the company acknowledges that its forward-looking statements are based on various assumptions that might evolve over time. Management's projections hinge on market research and industry trends prevalent at this time, recognizing potential economic pressures and regulatory changes that could influence their operational decisions.

As the cannabis industry continues to mature and adapt, Aurora Cannabis remains steadfast in its dedication to improving lives through its innovative products, and the ATM program is a testament to its forward-thinking financial strategy. Investors and stakeholders are encouraged to engage with the relevant prospectus to gain a more comprehensive understanding of Aurora's vision moving forward, emphasizing the importance of informed decision-making. With the global market for cannabis projected to grow exponentially, Aurora Cannabis stands poised to leverage its strong market presence, commitment to quality, and innovative financial strategies to navigate future challenges effectively.

For further updates and detailed information, interested parties can access the prospectus and related documents available on SEDAR+ and the SEC's EDGAR system. Additionally, Aurora invites followers to stay connected through its digital platforms, as it aims to Open the World to Cannabis™.